Bal Pharma Ratios

Bal Pharma Ltd Ratios

The Bal Pharma Ltd Ratios page provides a complete fundamental analysis of Bal Pharma Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Bal Pharma Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Bal Pharma Ltd (NSE: BALPHARMA, BSE: 524824) is currently trading at ₹64.87, with a market capitalization of ₹957.48M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Bal Pharma Ltd remains a key stock for fundamental analysis using Bal Pharma Ltd Ratios.

Bal Pharma Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Bal Pharma Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Bal Pharma Ltd Ratios.

Historically, the Bal Pharma Ltd P/E ratio has shown strong fluctuations:

The decline in Bal Pharma Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Bal Pharma Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Bal Pharma Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Bal Pharma Ltd P/S ratio currently stands at 0, an important part of Bal Pharma Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Bal Pharma Ltd P/S ratio indicates cautious market sentiment.

Bal Pharma Ltd Price to Cash Flow Ratio (P/CF)

The Bal Pharma Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Bal Pharma Ltd Price to Cash Flow Ratio:

The declining Bal Pharma Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Bal Pharma Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Bal Pharma Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Bal Pharma Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Bal Pharma Ltd EV/EBITDA ratio is currently 0, a key metric in Bal Pharma Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Bal Pharma Ltd EV/EBITDA indicates balanced valuation.

Bal Pharma Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Bal Pharma Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Bal Pharma Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Bal Pharma Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Bal Pharma Ltd Ratios Analysis Summary

The Bal Pharma Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Bal Pharma Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Bal Pharma Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.